Last $5.30 USD
Change Today -0.29 / -5.19%
Volume 5.3M
TXMD On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

therapeuticsmd inc (TXMD) Snapshot

Open
$5.57
Previous Close
$5.59
Day High
$5.57
Day Low
$5.09
52 Week High
03/6/14 - $9.01
52 Week Low
09/23/13 - $2.65
Market Cap
825.8M
Average Volume 10 Days
2.5M
EPS TTM
$-0.25
Shares Outstanding
155.8M
EX-Date
06/6/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THERAPEUTICSMD INC (TXMD)

Related News

No related news articles were found.

therapeuticsmd inc (TXMD) Related Businessweek News

No Related Businessweek News Found

therapeuticsmd inc (TXMD) Details

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

90 Employees
Last Reported Date: 08/7/14
Founded in 2008

therapeuticsmd inc (TXMD) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $448.3K
President, Secretary and Director
Total Annual Compensation: $363.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $324.6K
Chief Strategy Officer and Executive Vice Pre...
Total Annual Compensation: $200.0K
Compensation as of Fiscal Year 2013.

therapeuticsmd inc (TXMD) Key Developments

TherapeuticsMD, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

TherapeuticsMD, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported operating loss of $10,927,077, loss before taxes of $10,899,260, net loss of $10,899,260 or $0.07 net loss per basic and diluted share on revenues, net of $3,751,778 against operating loss of $5,616,994, loss before taxes of $6,009,646, net loss of $6,009,646 or $0.05 net loss per basic and diluted share on revenues, net of $2,080,885 for the same period a year ago. The increase in net revenue was largely driven by continued growth of the company's current women's health products, including the launch of additional prenatal vitamin products. For the six months, the company reported operating loss of $19,877,894, loss before taxes of $20,082,378, net loss of $20,082,378 or $0.14 net loss per basic and diluted share on revenues, net of $6,582,311 against operating loss of $10,559,885, loss before taxes of $12,385,299, net loss of $12,385,299 or $0.11 net loss per basic and diluted share on revenues, net of $3,618,080 for the same period a year ago. Net cash flows used in operating activities of $18,778,347 against $10,684,753 for the same period a year ago. Purchase of property and equipment was $30,962 against $22,905 for the same period a year ago.

TherapeuticsMD, Inc., Q2 2014 Earnings Call, Aug 06, 2014

TherapeuticsMD, Inc., Q2 2014 Earnings Call, Aug 06, 2014

TherapeuticsMD Mulls Acquisitions

TherapeuticsMD, Inc. (AMEX:TXMD) is looking for acquisition opportunities. TherapeuticsMD may also use a portion of the net proceeds to acquire or invest in complementary businesses, products, and technologies. Although they have no specific agreements, commitments or understandings with respect to any acquisition, they will evaluate acquisition opportunities and engage in related discussions with other companies from time to time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TXMD:US $5.30 USD -0.29

TXMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TXMD.
View Industry Companies
 

Industry Analysis

TXMD

Industry Average

Valuation TXMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 65.7x
Price/Book 20.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 67.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAPEUTICSMD INC, please visit www.therapeuticsmd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.